• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

  • in News
  • — 16 Mar, 2008
Robert Pirker
Robert Pirker

ROBERT PIRKER , Medical University of Vienna
Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR. Robert Pirker told the Turin congress he thinks is an emerging role for EGRF-targeted antibodies in lung cancer for patients who test positive for the epidermal growth factor receptor. He discussed the data with Peter Goodwin.

[audio:https://www.audiomedica.com/podcasting/oncology/080316_robert_pirker.mp3]

Tags: cancercetuximabimprovementslungmedicationmonoclonalpatientreceptorstudysurvivaltest

You may also like...

  • Early Breast Cancer Chemotherapy: Long Term Findings Early Breast Cancer Chemotherapy: Long Term Findings 8 Jan, 2008
  • Paracetamol use during pregnancy might put babies at risk of ADHD 28 Feb, 2014
  • Mathias Rummel Indolent Lymphoma Standard Therapy Needs To Change: Bendamustine-Rituximab: Better Than CHOP-Rituximab 7 Jun, 2012
  • Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer risk 6 Mar, 2014

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Lung Cancer Screening: Wait for Prospective Study Findings!
  • Next story Bevacizumab: New Standard for Non-Small Cell Lung Cancer?
  • News

    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
    • MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014
  • Related interviews

    • Women With DCIS Live Longer Than General Population
    • PD-L1 Checkpoint Inhibitor Immunotherapy Boosts…
    • Second-Generation ALK Inhibitor = Longer PFS in ALK+…
    • Adjuvant Checkpoint Inhibition Extends Disease-Free…
    • First-Line Pembrolizumab Boosts Survival in…
  • Home
  • News
  • Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

© COPYRIGHT 2013 AUDIOMEDICA.COM.